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In Korea, subtype B is the predominant variant of HIV‑1, but full genome sequencing and analysis 
of its viral variants are lacking. We performed near full‑length genome (NFLG) sequencing and 
phylogenetic and recombination analyses of fifty plasma samples from HIV‑positive men who have sex 
with men (MSM) from a Korea HIV/AIDS cohort study. Viral genomes were amplified and the near‑full‑
length sequences were determined using next‑generation sequencing (NGS) and Sanger sequencing. 
We focused on the HIV‑1 subtype classification and identification of HIV recombinants. Twelve HIV‑1 
NFLGs were determined: ten were subtyped as pure HIV‑1 subtype B and two recombinant strains as 
a common subtype CRF07_BC, and a novel subtype CRF43_02G recombined with CRF02_AG again, 
or a new CRF02_AG and subtype G recombinant. For the ten NFLGs determined by NGS, “the novel 
recombinant emerged at approximately 2003 and the other nine subtype B about 2004 or 2005”. 
This is the first report analyzing HIV‑1 NFLG, including recombinants and clinical characteristics, by 
subtype among MSM in Korea. Our results provide novel insights for understanding the recombinants 
in the HIV‑1 epidemic in Korea.
The human immunodeficiency virus (HIV) is characterized by extremely high genetic variability and rapid evo-
lution. This genetic variability results from the high mutation and recombination rate of reverse transcriptase, 
which lacks DNA proofreading capacity, together with high rates of viral replication. Insertions and deletions 
are also common in the HIV genome. This has resulted in high rates of intra- and inter-genetic recombination; 
therefore, HIV shows a more genetically diverse population with infected  hosts1,2. Recombinant viruses may 
contain distinct regions from two or more parental strains owing to simultaneous infection (co-infection) or 
sequential infection (super infection)3,4. HIV-1 recombination impacts many aspects of the HIV pandemic, 
including viral diversity and fitness, drug resistance, immunological escape, and disease progression. Recom-
binant viruses already contribute substantially to the global pandemic; currently, 104 circulating recombinant 
forms (CRFs) have been reported in the Los Alamos National Laboratory HIV Sequence Database (https ://www.
hiv.lanl.gov/conte nt/seque nce/HIV/CRFs/CRFs.html, last update; March 20, 2020). This number will increase 
as different HIV-1 subtypes are  discovered5.
The cumulative number of HIV cases in Korea since the first detected person with HIV in 1985 was report-
edly 18,725 as of 2019 and the sex ratio was 9.9:1 (male:female). Although cases of HIV infection in Korea are 
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relatively low compared to those in other countries, the number of newly diagnosed cases has increased annually. 
In addition, the proportion of HIV-diagnosed foreigners in Korea was approximately 11.0% of the total HIV 
cases. Further, 99.8% of all individuals diagnosed with HIV infection in Korea were infected through sexual 
contact, and transmission through blood transfusion, vertical transmission, and needle sharing for IDU was 
infrequent 6. For the past 30 years since 1985, the HIV-1 subtype B has been predominant, and the subtypes 
CRF_01AE, G, and C were observed in previous molecular surveys in Korea. A unique strain of HIV-1 subtype 
B, known as Korean clade B (Korean B), accounts for > 88% of subtype B infection cases in Korea. Most HIV-1 
strains are classified using phylogenetic analysis of small portion genome sequences, such as the gag, pol, or env 
 genes7,8. However, the recombination and sequence diversity of a complex genome cannot be completely charac-
terized when partial genome sequences are used for HIV-1 subtyping. Only full-length sequencing can determine 
the exact mosaic pattern within a recombinant virus  isolate9. The aim of the present study was to amplify the full-
length HIV-1 genome sequences of clinical isolates in Korea, and to perform genomic characterization through 
multiple recombination detection methods. To reconstruct an epidemiological history of HIV-1 in Korea, we 
further performed a Bayesian analysis of these Korean near full genome sequences.
Results
Characterization of study samples. Twelve near full-length genomes (NFLGs) were obtained from 
samples of fifty HIV-positive men who have sex with men (MSM). For twelve patients with NFLG, clinical 
and epidemiological characteristics are shown in Table 1. Their median age at diagnosis was 32 years (range 
21–51); the median  CD4+ T cell count was 85 cells/mm3 (range 7–677); and the median viral load was 210,527 
copies/mL (range 67,000–10,000,000); 91.7% (n = 11) received ART. A total of nine patients (75%), who had 
multiple symptoms, were diagnosed with AIDS-related/-defining disease: HIV-related tuberculosis (TB) (n = 4; 
33.3%), HIV-related syphilis (n = 5; 41.7%), oropharyngeal candidiasis (n = 3; 25.0%), and others (gonorrhea 
n = 1; 8.3%). Furthermore, no differences were observed in the patients of whom full-length genome sequence 
was not obtained. Supplementary Table S1 shows the epidemiological characteristics of the study population. 
For the fifty study participants, the median viral load was 145,031 copies/mL (range 63,890–10,000,000); the 
median  CD4+ T cell counts was 148 cells/mm3 (range 5–677); and forty-two participants (84.0%) received ART 
at the time of diagnosis.
Amplification of NFLG. For the NFLG of twelve samples, PCR amplicons of both fragments 1 (5.5 kb) and 
2 (3.7 kb) were obtained. As shown in Table 2, using next-generation sequencing (NGS) and Sanger sequencing, 
the assembly of the overlapping sequence contigs resulted in several different sequences, which were compared 
to HXB2, and ten sequences by NGS were used to characterize the near full-length HIV-1 genomes (8628–
8801 bp), ranging from the 5′-gag region to the 3′-nef region. Open reading frames were identified for the gag, 
pol, and env structural genes, and for the vif, vpr, vpu, nef, tat, and rev regulatory and accessory genes. Addition-
ally, Sanger sequencing identified the NFLGs of two samples, KR021 and KR050, that were 9237 bp in length and 
spanned from the gag to the nef genes. Almost all sequences (n = 12) were missing at the 5′ long terminal repeat 
Table 1.  Clinical characteristics of twelve HIV-positive men who have sex with men from which near 
full-length genomes were obtained in Korea. ART antiretroviral therapy, NNRTI non-nucleoside reverse 
transcriptase inhibitor. a Viral load was measured in copies/mL. CD4+T and CD8+T were measured in cells/
mm3. b Diseases diagnosed at entry of the study.







KR001 29 20,060,503 20,070,309 67,000 242 992 Naïve –
KR002 36 19,981,105 20,070,119 120,000 75 632 Experience Tuberculosis
KR004 41 20,070,221 20,070,220 220,000 50 255 Naïve Syphilis
KR005 17 20,070,130 20,070,201 110,000 493 1079 Naïve Tuberculosis
KR006 41 20,060,630 20,070,306 115,000 268 531 Naïve Syphilis
KR012 37 20,080,108 20,080,114 306,000 28 – Naïve oropharyngeal Candidiasis
KR014 18 20,071,213 20,080,123 550,000 77 931 Naïve NNRTI –




KR017 29 20,080,429 20,080,427 358,463 92 1500 Naïve –








KR050 21 20,160,113 20,160,719 254,000 138 1036 Naïve Syphilis
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(LTR) and 3′ LTR regions. We also amplified three partial genomes (gag, pol, and env) of samples using nested 
PCR (Supplementary information).
Recombinant analyses. NFLGs were mostly classified as HIV-1 subtype B (83%; 10/12), followed by 
recombinant forms (17%; 2/12). For the two recombinants, KR005 was classified as subtype A1 and subtype 
G recombinant, and KR050 was classified as CRF07_BC using jpHMM. Furthermore, recombination analysis 
using the REGA program showed that KR005 was a recombinant of CRF43_02G, subtype A1, and subtype G, 
and the other recombinant, KR050, was identified as CRF07_BC. The remaining ten samples were identified as 
subtype B. In particular, we also obtained recombinant events and breakpoints (BPs) from KR005 and KR050 
that were supported by at least three of the seven selected tests implemented in RDP4. The results of RDP4 
showed that KR005 was related to CRF02_G (AB485636) and CRF43_02G (EU697909). KR050 by RDP4 was 
shown to be related to CRF07_BC. A similar pattern and BP were observed in the sequences using jpHMM, 
REGA, and RDP4 (Table  2). We also analyzed three partial genomes of PCR-positive samples. The remain-
ing partial genome sequences included the gag for 39 samples (78%), pol for 32 samples (64%), and env for 29 
samples (58%). Overall, subtype B was the most prevalent and was classified as Korean subtype B (Korean B) 
(Supplementary Table S2).
Maximum likelihood (ML) phylogenetic analyses for NGS sequences. Phylogenetic analysis was 
performed to determine the genetic relatedness of 10 NFLG obtained by NGS. KR005 was found to be system-
atically located between subtype A and subtype G, and the remaining samples were clustered into subtype B, in 
particular, the reported reference sequences from Korea. KR017 was closely related to AY835771 and U34604 in 
USA (Fig. 1). ML phylogenetic analysis of KR005, the HIV-1 recombinant, showed that the CRF43_02G recom-
binant had the closest phylogenetic relationship with KR005 (Fig. 2). These results indicate that the parental 
origin of KR005 includes the CRF43_02G isolates. ML phylogeny analysis of the coding sequence (CDS) of each 
gene in NFLG showed that KR005 was closely related to subtype A based on the pol, vif, vpr, and vpu genes, and 
to subtype G based on the rev, env, and nef genes. The other samples strongly clustered within subtype B (Sup-
plementary Figure S1).
Estimation of the time to the most recent common ancestor (tMRCA) of HIV‑1 recombinants 
and subtype B strains. To determine the emergence time of HIV-1 recombinants and subtype B strains 
using Bayesian molecular clock analysis, ten NFLGs obtained by NGS were analyzed. As shown in Fig. 3, tMRCA 
of KR005 was estimated to be approximately 16 years before 2019 (divergence time (DT) = 15.6 years; 15.2 to 
16.0). The recent origin of the KR005 strains was estimated to be approximately 2003. One subtype B NFLG, 
KR017, was estimated to have emerged about 14 years ago (DT = 13.6 years; 12.0 to 15.3) from 2019. The other 
eight subtype B NFLGs originated from the same ancestor approximately 15 years ago (DT = 15.3 years; 11.1 to 
20.7) from 2019.
Clinical characteristics by subtype among MSM. We also analyzed the clinical data of twelve partici-
pants with NFLG. After 9 years of follow-up (range 0.5‒11 years), two patients with HIV recombinants and ten 
patients with HIV subtype B had median CD4 + T cell counts of 350 cells/mm3 (range 349‒352 cell/mm3; fol-
Table 2.  Summary of near full-length genomes from 12 HIV-1 samples with next-generation sequencing 
(NGS) and Sanger sequencing. a CRF, Circulating recombinant forms; Recombination events detected 
by jpHMM, REGA and RDP4; REGA, HIV subtyping tool; jpHMM, jumping profile HMM; RDP4, 




Summary of sequencing results
Sequence 
position Analyses







(%) Begin End jpHMM REGA RDP4
KR001
NGS
5777 8756 2328.89 98.6 790 9411 B B –
KR002 6003 8728 1349.06 90.0 790 9411 B B –
KR004 15,288 8768 2632.06 70.3 790 9411 B B –
KR005 11,920 8628 1699.36 95.7 841 9411 A1, G CRF43_02G, A1, G
CRF02_G, 
CRF43_02G
KR006 13,515 8785 5196.68 89.0 790 9411 B B –
KR012 10,069 8801 2305.98 90.3 790 9407 B B –
KR014 5200 8788 1531.72 33.9 790 9408 B B –
KR016 5457 8778 1632.23 90.0 790 9411 B B –
KR017 3721 8754 499.44 64.0 790 9411 B B –
KR020 8930 8768 2328.67 80.5 790 9411 B B –
KR021
Sanger
– 9237 – 95.0 658 9511 B B –
KR050 – 9237 – 95.0 538 9511 CRF07_BC CRF07_BC CRF07_BC
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low-up range 2 years) and 582 cells/mm3 (range 268‒896 cells/mm3; follow-up range 0.5‒11 years), respectively 
(Supplementary Figure S2). However, no significant difference in CD4 + T cell counts was observed between 
two groups after follow-up due to small sample size (p = 0.2374). The diseases status of all twelve patients during 
follow-up was investigated. Among the twelve patients who have been observed to multiple diseases, six were 

























































































































































































































Figure 1.  Recombinant analysis of near full-length genome sequences in MSM using phylogenetic analysis. 
Maximum likelihood tree of NFLG including study sequences in block line. Each subtype reference sequence is 
indicated in a different color. Numbers associated with tree branches indicate degrees of bootstrap support for 















































































































































Figure 2.  Phylogenetic tree of the recombinant of near full-length genome and genetic mosaic for the 
recombinant sequences classified using phylogeny. Maximum likelihood tree of NFLG KR005 indicated 
in red. Schematic representations of the breakpoint patterns in the right panel with related CRF references 
(CRF43_02G, CRF02_AG, and CRF63_02A).
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with condyloma (16%) (Supplementary Table S3). There was still no difference in disease characteristics during 
follow-up between two groups, the recombinants and subtype B.
Discussion
Here, we performed, for the first time, the identification of HIV-1 NFLG and the corresponding molecular 
evolution over time through Bayesian analysis from an HIV-positive MSM population in Korea. Furthermore, 
for the first time, we identified HIV-1 recombinants using multiple recombination detection methods and phy-
logenetic analysis. To the best of our knowledge, there is no other report of HIV-1 full genome sequencing from 
plasma RNA to identify viruses that are currently circulating in Korea. These results show that our methods were 
appropriate for HIV-1 full genome amplification. Subtype B sequences were the most common form identified 
using phylogenetic inference based on env, pol, gag, and near-full-length sequences. Monitoring of the HIV-1 
genome sequence in the virion is important because virion RNA reflects the currently replicating virus. Analy-
sis of virion RNA is preferable for the study of the pathogenesis and epidemiology of HIV-1 to proviral DNA 
present in  PBMC10. Several universal methods for amplifying and sequencing full HIV-1 genomes have been 
 reported11–13. However, we adapted the two large amplicons method of  Grossmann12, in which oligonucleotides 
have been developed based on simple and efficient protocols for diverse HIV-1  subtypes10,14. Furthermore, we 
first used plasma samples collected from a Korea HIV/AIDS cohort study. Viral RNA was extracted from a large 
volume (up to 2 mL) and high viral load (> 750,000 copies/mL) of HIV-1 infected plasma or serum specimens to 
conduct cDNA synthesis and successfully amplify  cDNA10,15. For viral genome sequencing, the Illumina MiSeq 
NGS is currently the most widely applied platform, but Illumina DNA polymerases can read ~ 250–300 bp in 
one direction, with a maximum of 600 bp paired-end reads. In this study, we used the Pacific Biosciences single 
molecule real-time (SMRT) sequencing technology, which generates extraordinarily long reads of average lengths 
between 10 and 15  kb16. To obtain more full-length sequences, we also used the Sanger sequencing method, 
although multiple primer pairs were required when analyzing sequences of large segments of HIV-1. In the pre-
sent study, we were able to obtain a higher proportion of HIV-1 NFLG from samples in our study (24%, 12/50) 
than in most of the other studies (approximately 10%)9,17.
For nearly completed genomes from MSM, the corresponding recombinant events were analyzed using 
different methods: REGA, jpHMM, RDP4, and ML phylogenetic analysis. Finally, the two near full genome 
recombinant variants were initially identified in Korea; KR050 as a common CRF07_BC and KR005 as a novel 
CRF43_02G. However, KR005 showed a close relationship with CRF02_AG in some regions. Thus, this may be 
an example of a CRF43_02G isolate that recombined with CRF02_AG again, or a new CRF02_AG and subtype 
G recombinant that came from the same population of viruses where CRF43_02G recombined. CRF43_02G, 

























































































































Figure 3.  Bayesian analysis of CRF43_02G recombinant sequence and pure B sequences from MSM by NGS. 
The scale axis below the tree shows the number of years before the present, and the ten clusters identified in our 
study are indicated by different colors. The ten near full genome sequences are shown in red.
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G in  200719. Therefore, the recombinant from KR005 could be described as a unique recombinant form (URF). 
However, owing to a lack of epidemiology information, such as where and when KR005 infection first occurred, 
we could not register it as a new URF or new CRF in the Los Alamos database. Several factors may contribute 
to the frequency and diversity of recombinant strains, such as co-circulation of multiple HIV-1 subtypes in the 
same  region20. CRF07_BC from the KR050 sample was a recombinant form between subtype B-Thai (B’) and C 
and was first described in 2000 21, but was known from western Yunnan, China, in the early 1990s. CRF07_BC is 
a major circulating recombinant form circulating in China 22. For the analysis of clinical data, including CD4 + T 
cell counts, there was no significant relationship between subtype and disease progression because of the small 
sample size. A previous study on sequence analysis of env gene in HIV-1 Korean B subtype showed that patients 
with Korean B variants displayed slower disease progression than those with the other  subtypes23. To understand 
or identify the viral effects on HIV disease progression, we suggest that a further study with a larger sample size 
and longer follow-up should be conducted.
In Korea, many epidemiological studies have been conducted using partial genome sequence, such as gag, pol, 
or env genes, and the proportion of Korean B was reported (87.3%)7,24,25. Several studies consistently reported 
this unique Korean clade B (Korean B), by analyzing various genes such as nef 24, env26, vif 27, and pol28,29. The 
Korean B strain has been the predominant strain in Korea for 26 years, since 1985. However, recombination and 
sequence diversity of a complex genome could not be completely characterized when partial genome sequences 
were used for HIV-1 subtyping.
In this study, we also performed subtype analysis of gag, pol, and env genes for each clinical sample. Unlike 
the full-length sequence analysis, the gag gene in KR005 was subtyped as A and env gene as G. Consequently, 
full genome sequencing should be performed to confirm the presence of novel circulating recombinants in these 
samples.
Regarding the Bayesian analysis, the introduction of KR005 sample in 2007 was probably a recent event dated 
by 2003. We suggested that the CRF43_02G recombinant strains were most likely circulating among Korean 
MSM since the estimated time by tMRCA.
HIV-1 recombinant viruses are prevalent in areas where multiple subtypes co-circulate, but they are infre-
quent in Korea where subtype B is predominant. However, to investigate the changes and characteristics of HIV 
recombinants in Korea, we need to identify and characterize NFLG periodically for cases of HIV diagnosed 
in Korea. This monitoring of HIV molecular epidemiology would be useful for predicting HIV epidemics and 
developing strategies for HIV prevention.
In conclusion, we identified a total of twelve HIV-1 NFLGs among fifty MSM plasma samples from a Korea 
HIV/AIDS cohort study. Two of them were revealed to be a novel CRF43_02G recombinant variant and a 
common CRF_07BC recombinant, whereas the remainder corresponded to the B subtype. We highlighted the 
importance of HIV-1 full-length genome analysis for the identification of new recombinant forms and clinical 
data analysis according to subtype among MSM, known as the major HIV high risk group in Korea. Regarding 
the recent status of HIV-1 epidemic in Korea, which has increased in terms of cases among young adults, males, 
and foreigners, there is a need for studies focusing on obtaining full genome sequences to better understand 
the impact of the viral diversity and dynamics of recombinants. Such events affect most aspects of the HIV 
pandemic; therefore, further studies are needed to improve the resolution of the HIV-1 genomic diversity and 
transmission dynamics.
Methods
Study samples. Plasma samples and data were obtained from a Korea HIV/AIDS cohort study that was 
established in 2006 for evidence-based prevention, treatment, and effective management of patients with HIV 
in  Korea30. The participants in the cohort were repeatedly surveyed, and blood samples were collected for six or 
twelve months. Data were managed by the cohort database system and samples were regularly stored in a LN2 
tank at − 196 °C at the National Biobank of Korea (NBK) in the Korea Centers for Diseases Control and Preven-
tion (KCDC). For the number of samples of HIV-1-infected MSM from the Korea HIV/AIDS Cohort Study, 50 
plasma samples were used based on the following conditions: the male infected due to MSM, the total potential 
number of samples (> 5 vials), viral load to enhance the sensitivity of amplification (> 10,000 copies/ml). We 
followed the NBK guidelines to obtain the samples, and this study was approved by KCDC Research Ethics 
Committee (2017-01-03).
Viral RNA extraction. Virions were initially concentrated from plasma by Centricon ultrafiltration (Ami-
con, Burlington, MA, USA). Viral RNA was extracted from 280 μL HIV-1 positive plasma using the QIAmp 
Viral RNA Mini Kit (Qiagen, Hilden, Germany).
Reverse transcription. NFLGs of samples were amplified in two fragments using nested PCR with differ-
ent gene-specific primer sets. Extracted RNA was immediately reverse transcribed to cDNA using the Super-
script III first-strand synthesis system (Invitrogen, Carlsbad, CA, USA). Briefly, RNA was primed with 6352R 
and 9605R (final concentration: 0.6 μM per primer). The reaction mixture was heated to 65 °C for 5 min and 
maintained at 45 °C until the addition of the second master mix. The final reaction mix was incubated for 2 h at 
45 °C, and finally at 85 °C for 5 min to terminate the reaction.
NFLG PCR and sequencing. NFLG amplification protocol for two regions was performed as described 
previously, with some  modifications12. The amplification primers used are listed in Supplementary Table S4. The 
first fragment (F1), of about 5.5 kb in length, consisted of the gag to vpu position (776–6231 relative to HXB2); 
the second fragment (F2), of approximately 3.7 kb in length, included the vif to 3LTR position (5861–9555 rela-
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tive to HXB2). For F1, the first round of PCR was performed with the 682F and 6352R primers, followed by a 
second round of nested PCR with the 776F and 6231R primers. The F2 fragment was amplified using the 5550F 
and 9555R primers and 5861F and 9555R primers by semi-nested PCR. Furthermore, the second round prim-
ers, which contained a set of 16 nt barcodes, were used for barcoded SMRT sequencing of the near-full-length 
HIV-1. PCR was performed for 30 cycles at 98 °C for 30 s, 55 °C for 30 s, and 68 °C for 6 min. For F2, the same 
cycling conditions were used, but with an extension time of 4 min. Two overlapping fragments were amplified 
using PrimeSTAR GXL DNA polymerase (TaKaRa Bio, Shiga, Japan), and a final primer concentration of 0.4 μM 
in 50 µl reaction mixtures. PCR products were purified using the direct QIAquick PCR purification kit accord-
ing to the manufacturer’s instructions (Qiagen). After quality check, the amplicons were sequenced using P6-C4 
chemistry on a PacBio RS II instrument (Pacific Biosciences, Menlo Park, CA, USA). Subgenome amplification 
and sequencing analysis are described in the Supplementary material.
Data analysis. Based on the HIV-1 reference sequence (HXB2; NCBI accession:  K0345531), PacBio 
sequence reads of each sample were mapped using the asm10 algorithm of minimap2 aligner v2.1732. To reduce 
the effects of cross-contamination, reads were filtered. Aligned PacBio sequence reads were assembled to con-
sensus sequences to develop the major genotype using SAMtools v1.933 and freebayes v1.234. Considering the 
sequencing error rates of PacBio  sequencing35, genotype variant calling was performed with minimum thresh-
olds of 0.3 for allele frequency, 30 for mapping quality and allele quality, and 100 for mapping coverage. Genetic 
regions of HIV-1 in the genomic sequences after the consensus assembly were annotated based on the HIV-1 
HXB2 reference genome  sequence31. Sanger sequences from each sample were aligned and assembled using 
GeneStudio v2.2 (GeneStudio, Inc., Suwanee, GA, USA). To improve the sequence accuracy, low-quality base 
callings from Sanger sequencing were trimmed out.
Recombination analysis. HIV-1 consensus sequences were subjected to recombinant analysis to deter-
mine their subtype/CRF classification. The mosaic recombinant structure was screened using several different 
strategies. The REGA HIV-1 subtyping tool v3 (Bioinformatic Bioafrica)36 and BPs were verified by the jump-
ing profile hidden Markov model (jpHMM; http://jphmm .gobic s.de)37. Recombination events were detected 
using RDP4 package (recombination detection program v.4):  RDP38,  GENECONV39,  BootScan40,  MaxChi41, 
 Chimera42,  SiScan43, and  3Seq44. Only break points detected using more than three methods with p < 0.05 were 
selected. As suggested in previous  studies17,45, the window size parameters were adjusted to 60 bp in RDP, 120 bp 
in MaxChi and Chimaera, and 500 bp in BootScan and SiScan; all other parameters were kept at the default 
values. The partial sequence alignments of each fragment were extracted from the genomic sequence alignment 
for the following phylogenetic analyses.
Maximum likelihood (ML) phylogenetic tree inference. Phylogenetic analyses were carried out to 
classify the isolates by HIV-1 subtype or CRFs. To infer the phylogenetic relationships and positions in HIV-1 
group M, phylogenetic analyses on the genome sequences, gene regions, and putative recombinant sequences 
were performed. Since the output sequences varied in length and quality depending on the methods of sequenc-
ing, the sequences obtained with NGS were subjected to phylogenetic analysis. For genomic phylogenetic analy-
sis (Fig. 1), up to ten genomic sequences from each pure subtype of HIV-1 group M, as in group taxa, and ten 
out-group genomic sequences from HIV-1 group O, were selected. The sequences were aligned with the default 
set of the ClustalW algorithm in MEGA X v10, followed by manual alignment adjustment. For phylogenetic 
analyses on gene regions (Supplementary Figure S1), the coding sequences of each gene were translated into 
their amino acid sequences and aligned with the default set of ClustalW with the BLOSUM matrix in MEGA 
 X46–48, followed by manual alignment adjustment. To improve reliability, we selected the results of phylogenetic 
tree reconstruction with 30 HIV-1 recombinant genome sequences with high similarity sequences, 10 sequences 
each of subtypes A and G as in-group taxa, and 10 sequences of subtype B for out-group taxa (Fig. 2). The most 
similar reference sequences were searched by HIV BLAST in the Los Alamos HIV sequence database (Supple-
mentary Table S5). The alignment method used was identical to that used for the genome sequence alignments 
described above. For ML analyses, IQ-TREE was used with 5000 UFBoot bootstrap  replicates49,50, and the sub-
stitution models for ML analyses in each fragment were selected by ModelFinder in the IQ-TREE  pipeline51.
Estimation of the time to the most recent common ancestor for HIV‑1 recombinants and sub‑
type B strain divergence. To understand the divergence time and evolutionary time scale of 10 HIV-1 
sequences obtained with NGS, molecular clock analysis with Bayesian inference was performed with BEAST 
v2.6 (burn-in = 25%)52. For Bayesian inference, the two most early genomic HIV-1 sequences  (MN08276853 and 
 KJ70479154) were included in the genomic sequence alignment, which was used in the genomic phylogenetic 
analysis above. Based on a previous study on the origin time and the evolutionary time scale of HIV-1 with 
partial sequence fragments of gag, pol, and env  genes55, a relaxed clock lognormal clock model and a coalescent 
Bayesian skyline tree model were selected with MCMC 10,000,000 generation for the inference. After inferring 
the monophyletic groups with preliminary analysis without any timescales, subtype-level monophyletic taxa 
were forced into monophyletic groups to ignore the false close relationships biased by sampling dates. The time-
scale of HIV-1 genomic evolution was inferred with tip dates of sampling (years); if this was not available, it was 
replaced by publication years (Supplementary Table S5).
Statistical analysis. Graphs were generated using Prism 5 software (GraphPad, La Jolla, CA, USA). The 
Mann–Whitney U test was used to check for statistical significance in our findings.
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Data availability
NFLG sequences from the study have been deposited in the GenBank with the Accession No. 
MT021899-MT021910.
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